Troy A. Ignelzi - 20 Aug 2021 Form 4 Insider Report for Karuna Therapeutics, Inc.

Role: Chief Financial Officer
Signature: /s/ Troy Ignelzi
Issuer symbol: N/A
Transactions as of: 20 Aug 2021
Net transactions value: +$46,000
Form type: 4
Filing time: 23 Aug 2021, 16:16:10 UTC
Previous filing: 16 Jun 2021
Next filing: 10 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KRTX	Common Stock	Options Exercise	$46,000	+5,000	+38%	$9.20^*	18,000	20 Aug 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KRTX	Option (right to buy)	Options Exercise	$0	-5,000	-2.6%	$0.000000	189,725	20 Aug 2021	Common Stock	5,000	$9.20	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option vested and became exercisable as to 1/4th of the shares underlying the option award on March 1, 2020, and continues to vest as to an additional 1/8th of the shares on each six month anniversary thereafter.